• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

角膜瘢痕组织形成的控制:临床及角膜组织工程中的策略

Control of scar tissue formation in the cornea: strategies in clinical and corneal tissue engineering.

作者信息

Wilson Samantha L, El Haj Alicia J, Yang Ying

机构信息

Institute for Science and Technology in Medicine, School of Medicine, Keele University, Staffordshire, ST4 7QB, UK.

出版信息

J Funct Biomater. 2012 Sep 18;3(3):642-87. doi: 10.3390/jfb3030642.

DOI:10.3390/jfb3030642
PMID:24955637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4031002/
Abstract

Corneal structure is highly organized and unified in architecture with structural and functional integration which mediates transparency and vision. Disease and injury are the second most common cause of blindness affecting over 10 million people worldwide. Ninety percent of blindness is permanent due to scarring and vascularization. Scarring caused via fibrotic cellular responses, heals the tissue, but fails to restore transparency. Controlling keratocyte activation and differentiation are key for the inhibition and prevention of fibrosis. Ophthalmic surgery techniques are continually developing to preserve and restore vision but corneal regression and scarring are often detrimental side effects and long term continuous follow up studies are lacking or discouraging. Appropriate corneal models may lead to a reduced need for corneal transplantation as presently there are insufficient numbers or suitable tissue to meet demand. Synthetic optical materials are under development for keratoprothesis although clinical use is limited due to implantation complications and high rejection rates. Tissue engineered corneas offer an alternative which more closely mimic the morphological, physiological and biomechanical properties of native corneas. However, replication of the native collagen fiber organization and retaining the phenotype of stromal cells which prevent scar-like tissue formation remains a challenge. Careful manipulation of culture environments are under investigation to determine a suitable environment that simulates native ECM organization and stimulates keratocyte migration and generation.

摘要

角膜结构在架构上高度有序且统一,具有结构和功能的整合,这介导了透明度和视力。疾病和损伤是导致失明的第二大常见原因,全球超过1000万人受其影响。90%的失明是永久性的,原因是瘢痕形成和血管化。由纤维化细胞反应引起的瘢痕形成可愈合组织,但无法恢复透明度。控制角膜细胞的激活和分化是抑制和预防纤维化的关键。眼科手术技术不断发展以保护和恢复视力,但角膜消退和瘢痕形成往往是有害的副作用,且缺乏长期持续的随访研究或结果不乐观。合适的角膜模型可能会减少角膜移植的需求,因为目前没有足够数量的合适组织来满足需求。用于角膜假体的合成光学材料正在研发中,尽管由于植入并发症和高排斥率,其临床应用有限。组织工程角膜提供了一种替代方案,它更紧密地模拟天然角膜的形态、生理和生物力学特性。然而,复制天然胶原纤维组织并保留防止瘢痕样组织形成的基质细胞表型仍然是一个挑战。正在研究仔细操控培养环境,以确定一个模拟天然细胞外基质组织并刺激角膜细胞迁移和生成的合适环境。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/4031002/8f3a1a2dc91c/jfb-03-00642-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/4031002/0a59c31ca333/jfb-03-00642-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/4031002/b870b815f7bf/jfb-03-00642-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/4031002/56fde9772879/jfb-03-00642-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/4031002/1a6db75dc4e6/jfb-03-00642-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/4031002/8f3a1a2dc91c/jfb-03-00642-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/4031002/0a59c31ca333/jfb-03-00642-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/4031002/b870b815f7bf/jfb-03-00642-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/4031002/56fde9772879/jfb-03-00642-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/4031002/1a6db75dc4e6/jfb-03-00642-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/4031002/8f3a1a2dc91c/jfb-03-00642-g005.jpg

相似文献

1
Control of scar tissue formation in the cornea: strategies in clinical and corneal tissue engineering.角膜瘢痕组织形成的控制:临床及角膜组织工程中的策略
J Funct Biomater. 2012 Sep 18;3(3):642-87. doi: 10.3390/jfb3030642.
2
Human cornea-derived extracellular matrix hydrogel for prevention of post-traumatic corneal scarring: A translational approach.人角膜细胞外基质水凝胶预防创伤后角膜瘢痕形成:一种转化方法。
Acta Biomater. 2023 Nov;171:289-307. doi: 10.1016/j.actbio.2023.09.002. Epub 2023 Sep 7.
3
Controlling human corneal stromal stem cell contraction to mediate rapid cell and matrix organization of real architecture for 3-dimensional tissue equivalents.控制人眼角膜基质干细胞收缩以介导快速细胞和基质组织,形成三维组织等效物的真实架构。
Acta Biomater. 2018 Feb;67:229-237. doi: 10.1016/j.actbio.2017.11.047. Epub 2017 Dec 5.
4
Corneal stromal stem cells restore transparency after N injury in mice.角膜基质干细胞在 N 损伤后恢复小鼠角膜透明性。
Stem Cells Transl Med. 2020 Aug;9(8):917-935. doi: 10.1002/sctm.19-0306. Epub 2020 May 7.
5
The Human Tissue-Engineered Cornea (hTEC): Recent Progress.人组织工程角膜(hTEC):最新进展。
Int J Mol Sci. 2021 Jan 28;22(3):1291. doi: 10.3390/ijms22031291.
6
Corneal regeneration: A review of stromal replacements.角膜再生:基质替代物综述。
Acta Biomater. 2018 Mar 15;69:31-41. doi: 10.1016/j.actbio.2018.01.023. Epub 2018 Feb 1.
7
Corneal stromal stem cells versus corneal fibroblasts in generating structurally appropriate corneal stromal tissue.角膜基质干细胞与角膜成纤维细胞在生成结构合适的角膜基质组织中的比较。
Exp Eye Res. 2014 Mar;120:71-81. doi: 10.1016/j.exer.2014.01.005. Epub 2014 Jan 15.
8
Recent Advancements in Molecular Therapeutics for Corneal Scar Treatment.分子治疗在角膜瘢痕治疗中的最新进展。
Cells. 2022 Oct 21;11(20):3310. doi: 10.3390/cells11203310.
9
Artificial Cornea Transplantation人工角膜移植
10
NBL1 Reduces Corneal Fibrosis and Scar Formation after Wounding.NBL1 可减少创伤后角膜纤维化和瘢痕形成。
Biomolecules. 2023 Oct 24;13(11):1570. doi: 10.3390/biom13111570.

引用本文的文献

1
Use of femtosecond laser generated reactive oxygen species to manage inflammation and enhance wound healing after ocular trauma.使用飞秒激光产生的活性氧来控制炎症并促进眼外伤后的伤口愈合。
Sci Rep. 2025 Jul 1;15(1):20794. doi: 10.1038/s41598-025-08541-x.
2
Drug-free hyaluronic acid-microneedle with unexpected inhibition activity on benzalkonium chloride-induced corneal inflammation and stromal scarring.无药物透明质酸微针制剂对苯扎氯铵诱导的角膜炎症和基质瘢痕形成具有意外的抑制活性。
Mater Today Bio. 2025 Mar 29;32:101722. doi: 10.1016/j.mtbio.2025.101722. eCollection 2025 Jun.
3
Analysis of Smad3 in the modulation of stromal extracellular matrix proteins in corneal scarring after alkali injury.

本文引用的文献

1
Growth factor regulation of corneal keratocyte mechanical phenotypes in 3-D collagen matrices.生长因子调节三维胶原基质中角膜成纤维细胞的力学表型。
Invest Ophthalmol Vis Sci. 2012 Mar 1;53(3):1077-86. doi: 10.1167/iovs.11-8609. Print 2012 Mar.
2
Corneal stromal cells use both high- and low-contractility migration mechanisms in 3-D collagen matrices.角膜基质细胞在 3D 胶原基质中使用高收缩力和低收缩力迁移机制。
Exp Cell Res. 2012 Apr 1;318(6):741-52. doi: 10.1016/j.yexcr.2011.12.018. Epub 2012 Jan 2.
3
Concentration-dependent effects of transforming growth factor β1 on corneal wound healing.
碱烧伤后角膜瘢痕形成过程中Smad3对基质细胞外基质蛋白调节作用的分析
Mol Vis. 2024 Dec 30;30:448-464. eCollection 2024.
4
Nanomedicine in Ophthalmology: From Bench to Bedside.眼科纳米医学:从实验台到病床边
J Clin Med. 2024 Dec 16;13(24):7651. doi: 10.3390/jcm13247651.
5
The Role of Adjunctive Triamcinolone Acetonide in Post-traumatic Vitreoretinal Surgery: Current Insights and Future Perspectives.曲安奈德在创伤后玻璃体视网膜手术中的辅助作用:当前见解与未来展望
Cureus. 2024 Oct 7;16(10):e71040. doi: 10.7759/cureus.71040. eCollection 2024 Oct.
6
Hepatocyte growth factor upregulates MMP1 and MMP10 expression and resolves corneal fibrosis.肝细胞生长因子上调 MMP1 和 MMP10 的表达并解决角膜纤维化。
Sci Rep. 2024 Nov 2;14(1):26421. doi: 10.1038/s41598-024-75488-w.
7
Precise longitudinal monitoring of corneal change through in vivo confocal microscopy in a rat dry eye disease model.通过在大鼠干眼疾病模型中的活体共聚焦显微镜对角膜变化进行精确的纵向监测。
Mol Vis. 2024 Mar 20;30:150-159. eCollection 2024.
8
Lipid nanoparticle technology-mediated therapeutic gene manipulation in the eyes.脂质纳米颗粒技术介导的眼部治疗性基因操控
Mol Ther Nucleic Acids. 2024 Jun 3;35(3):102236. doi: 10.1016/j.omtn.2024.102236. eCollection 2024 Sep 10.
9
Regenerative Therapy for Corneal Scarring Disorders.角膜瘢痕疾病的再生疗法
Biomedicines. 2024 Mar 14;12(3):649. doi: 10.3390/biomedicines12030649.
10
A meta-analysis of topical Ketorolac's effect on surgical site wound healing post-cataract surgery.一项关于局部用酮咯酸对白内障手术后手术部位伤口愈合影响的荟萃分析。
Int Wound J. 2024 Jan;21(1):e14661. doi: 10.1111/iwj.14661.
转化生长因子β1对角膜伤口愈合的浓度依赖性效应。
Mol Vis. 2011;17:2835-46. Epub 2011 Nov 2.
4
The engineering of organized human corneal tissue through the spatial guidance of corneal stromal stem cells.通过角膜基质干细胞的空间引导来构建有序的人眼角膜组织。
Biomaterials. 2012 Feb;33(5):1343-52. doi: 10.1016/j.biomaterials.2011.10.055. Epub 2011 Nov 10.
5
Transforming growth factor-β3 regulates assembly of a non-fibrotic matrix in a 3D corneal model.转化生长因子-β3 调节 3D 角膜模型中非纤维性基质的组装。
J Tissue Eng Regen Med. 2011 Aug;5(8):e228-38. doi: 10.1002/term.429. Epub 2011 May 23.
6
Decorin biology, expression, function and therapy in the cornea.角膜中 Decorin 的生物学、表达、功能和治疗。
Curr Mol Med. 2011 Mar;11(2):110-28. doi: 10.2174/156652411794859241.
7
Effect of microtopographical cues on human keratocyte orientation and gene expression.微形貌线索对人角膜基质细胞取向和基因表达的影响。
Curr Eye Res. 2011 Feb;36(2):88-93. doi: 10.3109/02713683.2010.512407.
8
Effects of fibroblast origin and phenotype on the proliferative potential of limbal epithelial progenitor cells.成纤维细胞来源和表型对角膜缘上皮祖细胞增殖潜能的影响。
Exp Eye Res. 2011 Jan;92(1):10-9. doi: 10.1016/j.exer.2010.10.004. Epub 2010 Oct 21.
9
Lumican is required for neutrophil extravasation following corneal injury and wound healing.层粘连蛋白对于角膜损伤和伤口愈合后的中性粒细胞渗出是必需的。
J Cell Sci. 2010 Sep 1;123(Pt 17):2987-95. doi: 10.1242/jcs.068221. Epub 2010 Aug 10.
10
A rabbit anterior cornea replacement derived from acellular porcine cornea matrix, epithelial cells and keratocytes.一种由去细胞猪角膜基质、上皮细胞和角膜基质细胞组成的兔前角膜替代物。
Biomaterials. 2010 Oct;31(28):7257-65. doi: 10.1016/j.biomaterials.2010.05.066. Epub 2010 Jul 2.